| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/20/2001 | DE10012413A1 Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 4,4'-Diarylbutadiene enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen Use of sunscreen combinations which comprise as an essential ingredient 4,4'-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations |
| 09/20/2001 | DE10012026A1 Stable aqueous gel containing polyhexamethylene biguanide, glycerol and hydroxyethyl cellulose, useful e.g. as washing or shower gel having decontaminant action or for covering wounds, |
| 09/20/2001 | CA2403679A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2403393A1 Methods and compositions for immunoregulation |
| 09/20/2001 | CA2403063A1 Polysaccharidic esters of n-derivatives of glutamic acid |
| 09/20/2001 | CA2403062A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2403017A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | CA2403000A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 09/20/2001 | CA2402891A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2402549A1 Substituted beta-carbolines |
| 09/20/2001 | CA2402248A1 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | CA2402120A1 The use of plant extracts and sugars to protect keratinous tissue |
| 09/20/2001 | CA2402025A1 Nystatin formulation having reduced toxicity |
| 09/20/2001 | CA2401267A1 Use of natural compounds having antiangiogenic activity |
| 09/20/2001 | CA2400106A1 Antibodies to human cd154 |
| 09/19/2001 | EP1134215A1 2-oxo-imidazolidine-4-carboxylic acid hydroxamine compounds that inhibit matrix metalloproteinases |
| 09/19/2001 | EP1133992A1 Novel pharmacological activities of curcuma longa extracts |
| 09/19/2001 | EP1133983A2 Self-foaming cleansing systems |
| 09/19/2001 | EP1133981A2 Use of light-screening combinations containing 4,4-Diarylbutadienes as photostable UV-filters in cosmetic and pharmaceutic preparations |
| 09/19/2001 | EP1133979A2 Use of specific fatty compounds for modifying the physico-chemical properties of the skin and/or the mucous membrane as agents for preventing or reducing the adhesion of micro-organisms thereon |
| 09/19/2001 | EP1133557A2 Growth factor modulators |
| 09/19/2001 | EP1133498A2 Amino-and mercurio-substituted 4', 5'-dihydropsoralens and therapeutical uses thereof |
| 09/19/2001 | EP1133494A1 8-azabicyclo 3.2.1]oct-2-ene and -octane derivatives |
| 09/19/2001 | EP1133488A1 Propanoic acid derivatives as integrin inhibitors |
| 09/19/2001 | EP1133487A1 Scavenger compounds |
| 09/19/2001 | EP1133486A2 Nonsteroidal antiinflammatories |
| 09/19/2001 | EP1133484A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 09/19/2001 | EP1133482A1 Il-5 inhibiting 6-azauracil derivatives |
| 09/19/2001 | EP1133481A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors |
| 09/19/2001 | EP1133480A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors |
| 09/19/2001 | EP1133477A1 Substituted benzimidazoles and their use as parp inhibitors |
| 09/19/2001 | EP1133471A1 Hydrazine derivatives |
| 09/19/2001 | EP1133467A1 Ion channel modulating agents |
| 09/19/2001 | EP1133317A1 Transport system conjugate |
| 09/19/2001 | EP1133300A1 Desmethylolanzapine compositions and methods |
| 09/19/2001 | EP1133275A1 Use of a synergistic mixture of polyphenols and vitamin compounds in cosmetic and dermatological compositions and methods for capturing free radicals on the skin and skin appendices |
| 09/19/2001 | EP0866804B1 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
| 09/19/2001 | EP0710111B1 Hormonal agent for the treatment of acne and its use |
| 09/19/2001 | EP0675712B1 Reduction of hair growth employing sulfhydryl reactive compounds |
| 09/19/2001 | CN1313903A Compound and method for the prevention and/or the treatment of allergy |
| 09/19/2001 | CN1313863A Inhibitors of urokinase and blood vessel fomation |
| 09/19/2001 | CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta |
| 09/19/2001 | CN1313753A Skin and tissue care and/or treatment agent |
| 09/19/2001 | CN1313124A Ointment for treating burn and its preparing process |
| 09/19/2001 | CN1313120A Face-beautifying buccal lozenge and its preparing process |
| 09/19/2001 | CN1313106A Broad-spectrum antibacterial Huangru Ointment for treating deep burn |
| 09/19/2001 | CN1313103A Pearl powder ointment for treating burn and scald |
| 09/19/2001 | CN1313097A Arsenic yellow ointment |
| 09/19/2001 | CN1313086A Use of fatty materials for prevention or reduction of microorganism adhere on skin and/or mucous membrane |
| 09/19/2001 | CN1071124C Pharmaceutical composition for treating bed sore and ulcerous wound surface |
| 09/19/2001 | CN1071112C Use in preparation of nutrients for skin care from cholesterine and phospholipid and its producing process |
| 09/18/2001 | US6291534 2,6- and 2,7-dimethoxynaphthalene |
| 09/18/2001 | US6291532 Use of N-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss |
| 09/18/2001 | US6291522 Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 09/18/2001 | US6291516 Contacting the cell with a composition including at least one cyclic amp agonist. |
| 09/18/2001 | US6291478 Compounds of the benzylaminodiacetamide family, compositions comprising them, preparation process and uses |
| 09/18/2001 | US6291468 Pyrimidine 3-oxide compounds for inducing/stimulating hair growth and/or retarding hair loss |
| 09/18/2001 | US6291457 Compounds having cytokine inhibitory activity |
| 09/18/2001 | US6291450 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 09/18/2001 | US6291425 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 09/18/2001 | US6290993 Compositions containing mimosa phenolic compounds |
| 09/18/2001 | US6290950 Mycosis vaccines |
| 09/18/2001 | CA2231118C Pharmaceutical preparation containing nimesulide for topical use |
| 09/18/2001 | CA1341293C Alpha-subunit of the mac-1 leukocyte adhesion receptor |
| 09/15/2001 | WO2001068859A2 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | CA2403370A1 Il-17 receptor like molecules and uses thereof |
| 09/13/2001 | WO2001066772A2 Heparinase iii and uses thereof |
| 09/13/2001 | WO2001066754A1 Human antibodies against eotaxin and their use |
| 09/13/2001 | WO2001066742A2 G-protein coupled receptors |
| 09/13/2001 | WO2001066706A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066698A1 Human cord blood as a source of neural tissue for repair of the brain and spinal cord |
| 09/13/2001 | WO2001066601A1 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 09/13/2001 | WO2001066595A2 Human fgf-23 gene and gene expression products |
| 09/13/2001 | WO2001066594A2 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | WO2001066550A2 Compounds for pdt |
| 09/13/2001 | WO2001066544A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 09/13/2001 | WO2001066525A1 New ccr5 modulators: benzimidazoles or benzotriazoles |
| 09/13/2001 | WO2001066164A1 Modified protein matrices |
| 09/13/2001 | WO2001066126A1 Sialoadhesin factor-2 antibodies |
| 09/13/2001 | WO2001066125A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4) |
| 09/13/2001 | WO2001066121A1 Oleoresin of hypericum perforatum l., method for obtaining said oleoresin and the use thereof |
| 09/13/2001 | WO2001066107A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 09/13/2001 | WO2001066101A2 Treatment of psoriasis |
| 09/13/2001 | WO2001066099A2 Use of quinazoline derivatives as angiogenesis inhibitors |
| 09/13/2001 | WO2001066076A2 Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions |
| 09/13/2001 | WO2001028993A3 Tyrosine kinase inhibitors |
| 09/13/2001 | WO2001028492A3 Polyanhydrides with biologically active degradation products |
| 09/13/2001 | WO2001028338A3 Antimicrobial compositions comprising a benzoic acid analog and a metal salt |
| 09/13/2001 | WO2001019542A8 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 09/13/2001 | WO2001016288A3 Dna encoding the human serine protease c-e |
| 09/13/2001 | WO2001015671A3 Flushable disposable polymeric products |
| 09/13/2001 | WO2001013926A3 Superoxidized water based on hypochlorous acid for the treatment of wounds |
| 09/13/2001 | WO2001009138A3 Chemokine receptor antagonists and methods of use therefor |
| 09/13/2001 | US20010021772 Vascular endothelial growth factor |
| 09/13/2001 | US20010021758 Drugs, medical diagnosis |
| 09/13/2001 | US20010021712 Antihistamines, antiallergens, brochodilator agents and antispasmodic agents |
| 09/13/2001 | US20010021397 Solvent extraction from yeast |
| 09/13/2001 | US20010021388 Cyclization of a triether with a diamine compound |
| 09/13/2001 | DE10010113A1 Isolation of collagen by extraction from sponge, giving product having cyclooxygenase inhibiting activity, useful for treating inflammatory diseases such as arthritis or skin inflammation |
| 09/13/2001 | CA2402433A1 Compounds for pdt |